AMERISAFE, Inc. (AMSF)

AMERISAFE pairs a fortress, debt-free balance sheet and a cheap 9.4x earnings / 1.6x book / 8.1% regular dividend-yield valuation with a clearly deteriorating underwriting cycle: the combined ratio has climbed for three straight years to 95.0% in 2026, EPS and book value per share are shrinking, operating cash flow is a fraction of net income, and the special dividend was not declared this year. Solvency risk is minimal and analyst and model price targets sit well above the current quote, but earnings quality and momentum argue for patience rather than action.

Dominant driver is the 2026-10-28 Q3 print (announced) - adjusted EPS $0.40 against roughly $0.48 consensus, revenue short of estimates, combined ratio 96.5% and gross premiums written -4.5% - tagged bearish on net market reception rather than the issuer's headline, with a follow-on Truist Hold with the target cut to $25 from $27 (2026-10-30, announced) confirming the read. Media sentiment deteriorated determinately from a roughly flat baseline (polarity_score near -0.05) to bearish (polarity_score near -0.30) in the 14-day scoring window with no offsetting bullish catalyst, which fires the moderate red-flag cap for sharply deteriorating sentiment (moderate red-flag cap applied), and there is no forward-dated catalyst inside the 30-day horizon.

Bearish/broken structure, not a tradable long setup on a 1-15 day horizon. Price 20.34 sits below sma20 24.27, sma50 24.56, sma200 30.64, ema9 22.41, ema21 23.62, wma9 21.98, wma21 23.69, dema14 21.81, tema14 20.81 and the 20.67 daily VWAP — a unanimous below-everything stack with no reclaimed level. Momentum is deteriorating rather than repairing: rsi14 22.21 (deeply oversold, down from 69.54 on 2026-10-22), williamsR14 -96.76, macdLine -0.98 under signal -0.39 with the histogram at -0.59 and widening, and adx14 32.67 rising from 25.65 — direction-agnostic ADX read together with price beneath every moving average is a strong DOWN trend, not a bullish trend-strength reading. The decline is -23.5% in nine sessions (26.58 on 2026-10-22 to 20.34), accelerating on the 2026-10-28 Q3 print and the -11.66% 2026-10-30 follow-through, and the close is only 1.0% above the 20.13 52-week low set on 2026-11-02. Volatility is adequate (atr14 0.94 = 4.62% of price, stdDev20 1.97) and liquidity is fine, so the chart is tradeable in principle — it is simply pointed the wrong way for a long. Oversold readings alone are a bounce hypothesis, not a reversal confirmation, and with MACD still expanding lower there is no evidence the sellers have exhausted.